Status | Study |
Recruiting |
Study Name: Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the Size of Sporadic Nodular Basal Cell Carcinomas Condition: Basal Cell Carcinomas Date: 2016-07-01 Interventions: Drug: patidegib gel 2% - cohort 1 |
Completed |
Study Name: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients Condition: Basal Cell Nevus Syndrome Date: 2016-04-27 Interventions: Drug: patidegib patidegib gel |
Active, not recruiting |
Study Name: Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Condition: Basal Cell Nevus Syndrome Date: 2014-06-02 Interventions: Drug: Levulan Levulan applicat |
Active, not recruiting |
Study Name: Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms Condition: Musculoskeletal Complications Date: 2013-07-02 Interventions: Dietary Supplement: levocarnitine |
Completed |
Study Name: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas Condition: Basal Cell Nevus Syndrome Gorlin's Syndrome Date: 2012-03-14 Interventions: Drug: Vismodegib 150 mg per da |
Completed |
Study Name: Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Gorlin Syndrome Date: 2011-05-06 Interventions: Drug: LDE225 supplied as 100 m |
Withdrawn |
Study Name: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Date: 2010-07-06 Interventions: Drug: LDE225B Cream, 2x daily |
Completed |
Study Name: A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions Condition: Basal Cell Carcinoma Date: 2009-11-16 |
Completed |
Study Name: A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients Condition: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients Date: 2009-08-18 Interventions: Drug: Vehicle Placebo cream |
Completed |
Study Name: To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) Condition: Basal Cell Nevus Syndrome Gorlin Syndrome Date: 2009-08-05 Interventions: Drug: GDC-0449 capsule, 150 mg, one pill daily, 18 months |